Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto, Evogene Enter Into R&D Collaboration

NEW YORK (GenomeWeb News) – Agriculture products giant Monsanto and Israeli ag-biotech company Evogene announced today that they have entered into a five-year research and development collaboration.
In the collaboration, Evogene will use its computer-based, predictive biology tools to pinpoint new candidate genes involved in plant yield, environmental stress, and fertilizer use. These genes will be tested and validated in model plants by Monsanto.
Under the terms of the agreement, Monsanto will have exclusive licensing rights to the newly identified genes in several crop plants, including corn, soybeans, canola, and cotton. It plans to evaluate licensed genes in its R&D pipeline and commercialize viable candidates through its branded and licensed businesses. The project is intended to move Monsanto closer to its goal of doubling its core crop yields by 2030.
For its part, Evogene is expected to receive roughly $35 million over the five-year collaboration through a combination of upfront payments and annual research payments. In addition, the company will be entitled to development milestone and royalty payments on products resulting from the collaboration.
Evogene and Monsanto have a history of research collaborations. Last September, they announced that they would collaborate on research meant to improve nitrogen use by corn, soybeans, canola, and cotton. Monsanto has also invested $18 million in Evogene and plans to purchase another $12 million stake in the company contingent on Evogene meeting specific “diligence requirements.”

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.